Skip to main content
Signal8

Taveras Arthur

SEC insider (Form 3/4/5 filer). CIK 0001830901. Chief Scientific Officer at X4 Pharmaceuticals, Inc (XFOR). 2 reported Form 4/5 transactions since Sep 2024; latest on Oct 7, 2024. Located in BOSTON, MA.

Companies Taveras Arthur has filed insider reports for

  • X4 Pharmaceuticals, Inc (XFOR): Officer, Chief Scientific Officer
Taveras Arthur profile photo

Taveras Arthur

CIK: 0001830901

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (50.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

X4 Pharmaceuticals, Inc logo
XFOR

X4 Pharmaceuticals, Inc

Officer

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • X4 Pharmaceuticals, Inc logo
    XFOR

    X4 Pharmaceuticals, Inc

    Oct 7, 2024
    Sale
    Direct
    76.9K shares at avg. $0.56$43K
  • X4 Pharmaceuticals, Inc logo
    XFOR

    X4 Pharmaceuticals, Inc

    Oct 4, 2024
    Award
    Direct
    230.6K shares-

1-2 of 2